HSD30 Incidence of Platinum-Resistant, Stage III/IV Ovarian Cancer Patients in the US: A Mixed Source Estimation Approach
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1253
https://www.valueinhealthjournal.com/article/S1098-3015(24)01368-8/fulltext
Section Title :
Section Order :
10654
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01368-8&doi=10.1016/j.jval.2024.03.1253